Tilray Medical’s FL Group has partnered with Italian pharma firm Molteni for pain and addiction therapies, it said on Wednesday.
The partnership is designed to broaden the availability of Tilray Medical, a division of Tilray Brands (NASDAQ:TLRY), cannabis extracts for patients across Italy.
Molteni will collaborate with FL Group by providing targeted education on medical cannabis therapies through Molteni’s comprehensive network of pharmaceutical, scientific, and medical professionals throughout Italy.
